HIGH RISK CLL

Clinical trials for HIGH RISK CLL explained in plain language.

Never miss a new study

Get alerted when new HIGH RISK CLL trials appear

Sign up with your email to follow new studies for HIGH RISK CLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Smart drug strategy targets hidden cancer cells in young CLL patients

Disease control Ongoing

This study tests a personalized treatment plan for young adults (18-65) with high-risk chronic lymphocytic leukemia (CLL) who have not had prior therapy. Patients first receive a combination of two drugs (venetoclax and obinutuzumab). Then, based on whether any cancer cells remai…

Matched conditions: HIGH RISK CLL

Phase: PHASE2 • Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Disease control

Last updated May 07, 2026 18:42 UTC

HIGH RISK CLL

Get alerted when new HIGH RISK CLL trials appear

Smart drug strategy targets hidden cancer cells in young CLL patients